Addition of dietary fat to cholesterol in the diets of LDL receptor knockout mice: effects on plasma insulin, lipoproteins, and atherosclerosis

被引:34
作者
Wu, Lan
Vikramadithyan, Reeba
Yu, Shuiqing
Pau, Clara
Hu, Yunying
Goldberg, Ira J.
Dansky, Hayes M. [1 ]
机构
[1] Columbia Univ, Dept Med, Med Ctr, Div Cardiol, New York, NY 10027 USA
[2] Columbia Univ, Dept Med, Med Ctr, Div Prevent Med, New York, NY USA
关键词
D O I
10.1194/jlr.M600146-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The factors underlying cardiovascular risk in patients with diabetes have not been clearly elucidated. Efforts to study this in mice have been hindered because the usual atherogenic diets that contain fat and cholesterol also lead to obesity and insulin resistance. We compared plasma glucose, insulin, and atherosclerotic lesion formation in LDL receptor knockout (Ldlr(-/-)) mice fed diets with varying fat and cholesterol content that induced similar lipoprotein profiles. Ldlr(-/-) mice fed a high-fat diet developed obesity, mild hyperglycemia, hyperinsulinemia, and hypertriglyceridemia. Quantitative and qualitative assessments of atherosclerosis were unchanged in diabetic Ldlr(-/-) mice fed a high-fat diet compared with lean nondiabetic control mice after 20 weeks of diet. Although one group of mice fed diets for 40 weeks had larger lesions at the aortic root, this was associated with a more atherogenic lipoprotein profile. The presence of a human aldose reductase transgene had no effect on atherosclerosis in fat-fed Ldlr(-/-) mice with mild diabetes. Our data suggest that when lipoprotein profiles are similar, addition of fat to a cholesterol-rich diet does not increase atherosclerotic lesion formation in Ldlr(-/-) mice.
引用
收藏
页码:2215 / 2222
页数:8
相关论文
共 50 条
[1]   NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older [J].
Alexander, CM ;
Landsman, PB ;
Teutsch, SM ;
Haffner, SM .
DIABETES, 2003, 52 (05) :1210-1214
[2]   Insulin causes endothelial dysfunction in humans - Sites and mechanisms [J].
Arcaro, G ;
Cretti, A ;
Balzano, S ;
Lechi, A ;
Muggeo, M ;
Bonora, E ;
Bonadonna, RC .
CIRCULATION, 2002, 105 (05) :576-582
[3]   Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes [J].
Basta, G ;
Schmidt, AM ;
De Caterina, R .
CARDIOVASCULAR RESEARCH, 2004, 63 (04) :582-592
[4]   Biochemistry and molecular cell biology of diabetic complications [J].
Brownlee, M .
NATURE, 2001, 414 (6865) :813-820
[5]   Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet [J].
Burcelin, M ;
Crivelli, V ;
Dacosta, A ;
Roy-Tirelli, A ;
Thorens, B .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2002, 282 (04) :E834-E842
[6]   Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice [J].
Collins, AR ;
Meehan, WP ;
Kintscher, U ;
Jackson, S ;
Wakino, S ;
Noh, G ;
Palinski, W ;
Hsueh, WA ;
Law, RE .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (03) :365-371
[7]  
Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3
[8]   Opposite effects of background genotype on muscle and liver insulin sensitivity of lipoatrophic mice [J].
Colombo, C ;
Haluzik, M ;
Cutson, JJ ;
Dietz, KR ;
Marcus-Samuels, B ;
Vinson, C ;
Gavrilova, O ;
Reitman, ML .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (06) :3992-3999
[9]   The relationship between glucose and incident cardiovascular events [J].
Coutinho, M ;
Gerstein, HC ;
Wang, Y ;
Yusuf, S .
DIABETES CARE, 1999, 22 (02) :233-240
[10]   Diabetes and vascular disease -: Pathophysiology, clinical consequences, and medical therapy:: Part I [J].
Creager, MA ;
Lüscher, TF ;
Cosentino, F ;
Beckman, JA .
CIRCULATION, 2003, 108 (12) :1527-1532